These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Nucleocytoplasmic trafficking and transcription effects of huntingtin in Huntington's disease. Truant R; Atwal RS; Burtnik A Prog Neurobiol; 2007 Nov; 83(4):211-27. PubMed ID: 17240517 [TBL] [Abstract][Full Text] [Related]
4. Targeting several CAG expansion diseases by a single antisense oligonucleotide. Evers MM; Pepers BA; van Deutekom JC; Mulders SA; den Dunnen JT; Aartsma-Rus A; van Ommen GJ; van Roon-Mom WM PLoS One; 2011; 6(9):e24308. PubMed ID: 21909428 [TBL] [Abstract][Full Text] [Related]
5. Huntingtin-protein interactions and the pathogenesis of Huntington's disease. Li SH; Li XJ Trends Genet; 2004 Mar; 20(3):146-54. PubMed ID: 15036808 [TBL] [Abstract][Full Text] [Related]
6. The spinocerebellar ataxia type 1 protein, ataxin-1, has RNA-binding activity that is inversely affected by the length of its polyglutamine tract. Yue S; Serra HG; Zoghbi HY; Orr HT Hum Mol Genet; 2001 Jan; 10(1):25-30. PubMed ID: 11136710 [TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of genetic modifiers in Drosophila points to common and distinct mechanisms of pathogenesis among polyglutamine diseases. Branco J; Al-Ramahi I; Ukani L; Pérez AM; Fernandez-Funez P; Rincón-Limas D; Botas J Hum Mol Genet; 2008 Feb; 17(3):376-90. PubMed ID: 17984172 [TBL] [Abstract][Full Text] [Related]
9. Insoluble TATA-binding protein accumulation in Huntington's disease cortex. van Roon-Mom WM; Reid SJ; Jones AL; MacDonald ME; Faull RL; Snell RG Brain Res Mol Brain Res; 2002 Dec; 109(1-2):1-10. PubMed ID: 12531510 [TBL] [Abstract][Full Text] [Related]
10. Is Huntington's a glutamine storage disease? Brusilow WS Neuroscientist; 2006 Aug; 12(4):300-4. PubMed ID: 16840706 [TBL] [Abstract][Full Text] [Related]
11. Canadian Association of Neurosciences Review: polyglutamine expansion neurodegenerative diseases. Truant R; Raymond LA; Xia J; Pinchev D; Burtnik A; Atwal RS Can J Neurol Sci; 2006 Aug; 33(3):278-91. PubMed ID: 17001815 [TBL] [Abstract][Full Text] [Related]
12. Huntington's disease-like and ataxia syndromes: identification of a family with a de novo SCA17/TBP mutation. Bech S; Petersen T; Nørremølle A; Gjedde A; Ehlers L; Eiberg H; Hjermind LE; Hasholt L; Lundorf E; Nielsen JE Parkinsonism Relat Disord; 2010 Jan; 16(1):12-5. PubMed ID: 19595623 [TBL] [Abstract][Full Text] [Related]
13. Polyglutamine expansion mutation yields a pathological epitope linked to nucleation of protein aggregate: determinant of Huntington's disease onset. Sugaya K; Matsubara S; Kagamihara Y; Kawata A; Hayashi H PLoS One; 2007 Jul; 2(7):e635. PubMed ID: 17653262 [TBL] [Abstract][Full Text] [Related]
14. A huntingtin-associated protein enriched in brain with implications for pathology. Li XJ; Li SH; Sharp AH; Nucifora FC; Schilling G; Lanahan A; Worley P; Snyder SH; Ross CA Nature; 1995 Nov; 378(6555):398-402. PubMed ID: 7477378 [TBL] [Abstract][Full Text] [Related]
15. SCA17, a novel autosomal dominant cerebellar ataxia caused by an expanded polyglutamine in TATA-binding protein. Nakamura K; Jeong SY; Uchihara T; Anno M; Nagashima K; Nagashima T; Ikeda S; Tsuji S; Kanazawa I Hum Mol Genet; 2001 Jul; 10(14):1441-8. PubMed ID: 11448935 [TBL] [Abstract][Full Text] [Related]
16. New clues found to Huntington's. Barinaga M Science; 1995 Nov; 270(5239):1110. PubMed ID: 7502028 [No Abstract] [Full Text] [Related]
17. Identification and localization of ataxin-7 in brain and retina of a patient with cerebellar ataxia type II using anti-peptide antibody. Mauger C; Del-Favero J; Ceuterick C; Lübke U; van Broeckhoven C; Martin J Brain Res Mol Brain Res; 1999 Dec; 74(1-2):35-43. PubMed ID: 10640674 [TBL] [Abstract][Full Text] [Related]
18. Properties of polyglutamine expansion in vitro and in a cellular model for Huntington's disease. Lunkes A; Trottier Y; Fagart J; Schultz P; Zeder-Lutz G; Moras D; Mandel JL Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1013-9. PubMed ID: 10434300 [TBL] [Abstract][Full Text] [Related]
19. [SCA17, a novel polyglutamine disease caused by the expansion of polyglutamine tracts in TATA-binding protein]. Nakamura K Rinsho Shinkeigaku; 2001 Dec; 41(12):1123-5. PubMed ID: 12235815 [TBL] [Abstract][Full Text] [Related]
20. Progress in pathogenesis studies of spinocerebellar ataxia type 1. Cummings CJ; Orr HT; Zoghbi HY Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1079-81. PubMed ID: 10434309 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]